HOME >> BIOLOGY >> NEWS
Site of US Open at Bethpage is reducing pesticide use

older courses in the Northeast. Rossi says that conducting research on reducing pesticide use is a challenge on any course, particularly one so busy. "Everybody talks about thinking outside the box. With our project, there is no box. No one has ever tried to do anything like this before," he says. "We've become so reliant on pesticide chemistry that to completely remove it is a formidable challenge."

One of the Green course's toughest putting-green pests is a fungus called dollar spot, which produces small, tan-colored, circular spots in the turf about the size of silver dollars. It is a common, easy-to-control disease when typical pesticides are available.

Without pesticides applied at this early stage, dollar spot has devastated greens in the past. Today, though, greenskeepers remove the morning dew from the greens every day to reduce the fungal infection, Grant says. They also are able to delay the use of fungicides by vigilantly monitoring the turf and only treating when and where necessary. "It's still a challenge," she says.

In another effort to check diseases, velvet bentgrass has been installed on holes 7, 10 and 15 as a test. Typically the grass -- with its velvetlike texture -- is used on more northern or maritime golf courses. It can withstand the close mowing heights required for a good putting surface but is much less susceptible to disease than creeping bentgrass or annual bluegrass, the more popular putting-green grasses in the Northeast.

Organic compost also has been helpful. During the winter, under the instruction of the turf scientists, the greenskeepers covered half the greens with organic compost to halt snow mold development. While preventing the fungus from growing, the compost fed the greens with nitrogen and micronutrients -- possibly making the greens stronger and more able to resist future mold attacks. In February the compost was removed from the greens before the grass started to grow.

Early in
'"/>

Contact: Blaine P. Friedlander Jr.
bpf2@cornell.edu
607-255-3290
Cornell University News Service
6-Jun-2002


Page: 1 2 3

Related biology news :

1. Medication reconciliation, pharmacist involvement vital to reducing medication errors, study finds
2. New compound highly efficacious at reducing human tumour growth
3. Estrogens as antioxidants reducing heart disease in younger postmenopausal women
4. A new approach holds promise for reducing cocaine craving
5. WCS launches new program aimed at reducing unsustainable hunting overseas
6. Study of key enzyme sheds new light on programmed cell death and may lead to new drugs for reducing the severity of stroke
7. Acute zinc depletion affects homeostasis by reducing the rate of release from skeletal muscle
8. Effect of exercise on reducing major depression appears to be long-lasting
9. Balanced diet lowers homocysteine, reducing risk of heart disease
10. Exercise and weight loss effective in reducing high blood pressure for overweight individuals
11. Sediments in many Central Valley streams contain toxic levels of pyrethroid pesticides

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Site Open Bethpage reducing pesticide use

(Date:12/17/2014)... RALEIGH, N.C. , Dec. 16, 2014 ... has licensed its PerformTek biometric technology to industry leaders ... their highly accurate, clinically validated, biometric wearable products. These ... January 6-9 in Las Vegas . ... the technology is accurate, flexible and robust – with ...
(Date:12/11/2014)... 2014 Research and Markets ... ( http://www.researchandmarkets.com/research/twhjll/biometrics_market ) has announced the addition of ... 2015-2019"  report to their offering. ... advances in technology. With continuous advances in technology, ... the latest standard that meets the needs and ...
(Date:12/10/2014)... 2014 You,ve been here before: you desperately need ... your password, site key or the answer to your secret ... teacher? Today, Hoyos Labs , a ... will finally put an end to the frustration that comes ... . 1U leverages a user,s smartphone to acquire his or ...
Breaking Biology News(10 mins):Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 2The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 3
(Date:12/17/2014)... (PRWEB) December 17, 2014 Gene ... that it has entered into a technology access ... (ADM) to apply DNA2.0’s proprietary protein engineering technology, ... process. , “We are extremely excited that the ... platform. This proprietary bioengineering technology has now ...
(Date:12/17/2014)... SOUTH SAN FRANCISCO, Calif. , Dec. 17, ... positive results of a Phase 2 study evaluating ... for the treatment of patients with severe, chronic ... the current standard of care, including topical steroids ... endpoint was percent change in Visual Analog Scale ...
(Date:12/15/2014)...  GlassesOff Inc. (OTCBB: GLSO) announced today the appointment ... director of the Company,s Board of Directors. ... its CEO until its acquisition by Stanley Black ... Recognized as the inventor of the first Wi-Fi-based Active ... -based RFID solutions focused on improving operational efficiency, safety ...
(Date:12/13/2014)... (PRWEB) December 12, 2014 Clarassance, a ... announced its new name: Therabron Therapeutics , Inc. ... and bronchioles (a type of structure in the lungs ... company’s mission to develop novel protein therapeutics for the ... directors decided to change the name to mark the ...
Breaking Biology Technology:ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 3Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 4AeroScout Founder Joins GlassesOff's Board of Directors 2AeroScout Founder Joins GlassesOff's Board of Directors 3Maryland-based Biotech Company's Path Forward in Treating Respiratory Diseases Sparks Name Change 2
Cached News: